(Q44852166)

6 December 2017

title

Relative bioavailability of an extemporaneous ondansetron 4-mg capsule formulation versus solution (English)

1 reference

6 December 2017

Y W Francis Lam

1

1 reference

6 December 2017

Martin A Javors

2

1 reference

6 December 2017

Nassima Ait-Daoud

3

1 reference

6 December 2017

John D Roache

4

1 reference

6 December 2017

Bankole A Johnson

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

477-481

1 reference

Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.5.477.33353

5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.5.477.33353

Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.5.477.33353

Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.5.477.33353

Ondansetron absorption in adults: effect of dosage form, food, and antacids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.5.477.33353

10.1592/PHCO.24.5.477.33353

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference